LAG-3–associated CD8+ T-cell dysfunction in the cervical cancer tumor microenvironment

Puntos clave

• LAG-3 expression correlates significantly with clinical stage and lymph node metastasis, indicating its role in tumor behavior.
• LAG-3 appears to inhibit CD8+ T-cell function, which may promote cervical cancer development and spread in patients.
• Assessment of tumor samples revealed high LAG-3 levels associated with poor differentiation and lymphovascular invasion.
• Findings highlight the need for targeting LAG-3 in therapeutic strategies to enhance CD8+ T-cell responses against cervical cancer.